Physician profile
Eric M Haas
NPI 1275501603
$140,353.83
in general payments reported to CMS, 2019-2025
22 companies · $804 in 2025
The $804 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $34K · 2021: $8,198 · 2022: $15K · 2023: $3,744 · 2024: $21K · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Consulting Fee: $8,756 · Food and Beverage: $4,051 · Travel and Lodging: $2,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Consulting Fee | $8,755.60 |
| Food and Beverage | $4,051.03 |
| Travel and Lodging | $2,262.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $100,733.13 | 2019-2025 | Da Vinci Surgical System |
| Thd America, INC. | $11,841.70 | 2023-2025 | |
| Axonics, INC. | $11,596.19 | 2022-2024 | Axonics, Bulkamid |
| Ethicon INC. | $6,565.00 | 2020-2021 | |
| Applied Medical Resources Corporation | $6,000.00 | 2019 | |
| Ethicon US, LLC | $630.56 | 2019-2025 | Echelon Flex, Smartablatetm System Rf Generator, Monocryl |
| Medtronic, INC. | $621.18 | 2022-2025 | V-Loc 180, Signia, Ligasure |
| Davol INC. | $548.30 | 2020 | |
| Covidien LP | $536.18 | 2019-2020 | |
| Activ Surgical, INC. | $225.20 | 2024 | Activsight |
| Tela Bio, INC. | $197.18 | 2020-2021 | |
| W. L. Gore & Associates, INC. | $167.50 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Baxter Healthcare | $148.45 | 2024 | Perclot |
| Integra Lifesciences Corporation | $117.53 | 2024-2025 | Integra, Surgimend, Omnigraft |
| Pacira Pharmaceuticals Incorporated | $101.82 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $101.53 | 2025 | Axonics |
| Olympus America INC. | $89.86 | 2019 | |
| Apollo Endosurgery US INC | $81.79 | 2019 | |
| Heron Therapeutics, INC. | $29.85 | 2025 | Zynrelef |
| Laborie Medical Technologies Corp. | $20.88 | 2023 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.